Skip to main content
SpringerLink
Log in

Dynorphin Peptides: Antagonists of Melanocortin Receptors

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To identify possible targets that mediate the non-opioid effects of dynorphin A (DynA), effects that include inflammation and aggravation of traumatic nerve injury.

Methods. We examined dynorphin peptides for functional interaction with the closely related melanocortin (MC) system.

Results. DynA-(l-13)NH2 and other related opioid dynorphin peptides antagonize the human MC1, MC3 and MC4 receptors, and an amphibian MC receptor, with dissociation constants (Kd's) of 40 to 150 nM. The affinity of dynorphin's interaction with MC receptors is therefore greater than with other previously proposed non-opioid targets of dynorphin, which require micromolar concentrations. Dynorphin also antagonizes the adrenocorticotropic hormone (ACTH; MC2) receptor and an MC-like receptor endogenous to COS-7 cells, but with lower efficacy. In contrast DynA had no effect on seven control receptors and was only weakly effective at two others. Metabolites of dynorphin derived from cleavage of the amino terminal Tyr residue, such as DynA(2-17), lack opioid activity yet still produce a number of well established non-opioid effects. These des-Tyr derivatives also antagonized each of the five MC receptors examined.

Conclusions. DynA peptides were found to antagonize MC receptorsin vitro with potencies that parallel those reported for pharmacological non-opioid effects of dynorphins in vivo. The combination of DynA and its active metabolites may reach levels sufficient to inhibit MC receptors physiologically. Dynorphin inhibition of MC receptors could prove to be an example of crosstalk between two distinct yet phylogenetically related neurotransmitter systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. L. Stanfa, and A. Dickenson. Inflamm. Res. 44:231–41 (1995).

    PubMed  Google Scholar 

  2. J. M. Walker, H. C. Moises, D. H. Coy, G. Baldrighi, and H. Akil. Science 218:1136–8 (1982).

    PubMed  Google Scholar 

  3. H. Akil, S. J. Watson, E. Young, M. E. Lewis, H. Khachaturian, and J. M. Walker. Ann. Rev. Neurosci. 7:223–55 (1984).

    PubMed  Google Scholar 

  4. R. Poggioli, A. V. Vergoni, and A. Bertolini. Peptides 7:843–8 (1986).

    PubMed  Google Scholar 

  5. A. I. Faden. J. Neurosci. 12:425–9 (1992).

    PubMed  Google Scholar 

  6. V. K. Shukla, and S. Lemaire. Trends Pharmacol. Sci. 15:420–4 (1994).

    PubMed  Google Scholar 

  7. M. Dumont, and S. Lemaire J. Mol. Cell Cardiol. 25:983–91 (1993).

    PubMed  Google Scholar 

  8. C. Chavkin, I. F. James, and A. Goldstein. Science 215:413–5 (1982).

    PubMed  Google Scholar 

  9. S. Zhang, and L. Yu. J. Biol. Chem. 270:22772–6 (1995).

    PubMed  Google Scholar 

  10. M. Miura, A. Inui, K. Sano, N. Ueno, A. Teranishi, Y. Hirosue, M. Nakajima, M. Okita, J. Togami, K. Koshiya, S. Baba, and M. Kasuga. Am. J. Physiol. 267:E702–9 (1994).

    PubMed  Google Scholar 

  11. W. H. Gispen, J. Buitelaar, V. M. Wiegant, L. Terenius, and D. De Wied. Eur. J. Pharmacol. 39:393–7 (1976).

    PubMed  Google Scholar 

  12. M. E. Hadley. The Melanotropic Peptides, Vols 1–3, CRC Press Inc., Boca Raton, Florida, 1988.

    Google Scholar 

  13. A. N. Eberle. The Melanotropins: Chemistry, Physiology and Mechanism of Action, Karger, Basel, Switzerland, 1988.

    Google Scholar 

  14. J. M. Walker, H. C. Moises, D. H. Coy, E. A. Young, S. J. Watson, and H. Akil. Life Sci. 31:1821–4 (1982).

    PubMed  Google Scholar 

  15. A. E. Takemori, H. H. Loh, and N. M. Lee. J. Pharmacol. Exp. Ther. 266:121–4 (1993).

    PubMed  Google Scholar 

  16. L. P. Hooke, L. He, and N. M. Lee. J. Pharmacol. Exp. Ther. 273:292–7 (1995).

    PubMed  Google Scholar 

  17. P. C. Contreras and A. E. Takemori. J. Pharmacol. Exp. Ther. 229:21–6 (1984).

    PubMed  Google Scholar 

  18. J. I. Szekely, E. Miglecz, Z. Dunai-Kovacs, I. Tarnawa, A. Z. Ronai, L. Graf, and S. Bajusz. Life Sci. 24:1931–8 (1979).

    PubMed  Google Scholar 

  19. A. Bertolini, S. Guarini, E. Rompianesi, and W. Ferrari. Eur. J. Pharmacol. 130:19–26 (1986).

    PubMed  Google Scholar 

  20. J. D. Alvaro, J. B. Tatro, J. M. Quillan, M. Fogliano, M. Eisenhard, M. R. Lerner, E. J. Nestler, and R. S. Duman. Mol. Pharm. 50:583–91 (1996).

    Google Scholar 

  21. A. Bertolini, S. Guarini, W. Ferrari, and E. Rompianesi. Life Sci. 39:1271–80 (1986).

    Article  PubMed  Google Scholar 

  22. J. M. Quillan and W. Sadée. Pharm. Res. 13:1622–28 (1996).

    Article  Google Scholar 

  23. A. Daniolos, A. B. Lerner, and M. R. Lerner. Pigment Cell Res. 3:38–43 (1990).

    PubMed  Google Scholar 

  24. J. M. Quillan, C. K. Jayawickreme, and M. R. Lerner. Proc. Natl. Acad. Sci. (USA) 92:2894–98 (1995).

    Google Scholar 

  25. J. M. Quillan. Development of a Combinatorial Diffusion Assay and Discovery of MSH Receptor Antagonists, UMI, Ann Arbour, Michigan, 1995.

    Google Scholar 

  26. G. Weng, F. Yee, P. Michl, D. Reis, and C. Wahlestedt. Mol. Pharmacol. 48:9–14 (1995).

    PubMed  Google Scholar 

  27. W. E. Polgar, C. M. Bitler, and L. Toll. Life Sci. 58:1223–9 (1996).

    Article  PubMed  Google Scholar 

  28. L. Chen, Y. Gu, and L. Y. Huang. J. Neurosci. 15:4602–11 (1995).

    PubMed  Google Scholar 

  29. J. M. Walker, G. G. Berntson, C. A. Sandman, A. J. Kastin, and H. Akil. Eur. J. Pharmacol. 69:71–9 (1981).

    Article  PubMed  Google Scholar 

  30. P. C. Datta, C. A. Sandman, and F. K. Hoehler. Peptides 3:433–7 (1982).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, University of California Medical Center, San Francisco, California, 94143-0446

    J. Mark Quillan & Wolfgang Sadée

Authors
  1. J. Mark Quillan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Sadée
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quillan, J.M., Sadée, W. Dynorphin Peptides: Antagonists of Melanocortin Receptors. Pharm Res 14, 713–719 (1997). https://doi.org/10.1023/A:1012185919153

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012185919153

Search

Navigation